1. Home
  2. YMAB vs BOC Comparison

YMAB vs BOC Comparison

Compare YMAB & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • BOC
  • Stock Information
  • Founded
  • YMAB 2015
  • BOC 2009
  • Country
  • YMAB United States
  • BOC United States
  • Employees
  • YMAB N/A
  • BOC N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • BOC
  • Sector
  • YMAB Health Care
  • BOC
  • Exchange
  • YMAB Nasdaq
  • BOC Nasdaq
  • Market Cap
  • YMAB 482.4M
  • BOC 482.5M
  • IPO Year
  • YMAB 2018
  • BOC 2017
  • Fundamental
  • Price
  • YMAB $9.38
  • BOC $14.70
  • Analyst Decision
  • YMAB Strong Buy
  • BOC Buy
  • Analyst Count
  • YMAB 10
  • BOC 3
  • Target Price
  • YMAB $21.00
  • BOC $20.00
  • AVG Volume (30 Days)
  • YMAB 243.1K
  • BOC 99.5K
  • Earning Date
  • YMAB 11-08-2024
  • BOC 11-12-2024
  • Dividend Yield
  • YMAB N/A
  • BOC N/A
  • EPS Growth
  • YMAB N/A
  • BOC N/A
  • EPS
  • YMAB N/A
  • BOC N/A
  • Revenue
  • YMAB $84,553,000.00
  • BOC $105,014,906.00
  • Revenue This Year
  • YMAB $6.46
  • BOC $13.57
  • Revenue Next Year
  • YMAB $20.68
  • BOC $7.47
  • P/E Ratio
  • YMAB N/A
  • BOC N/A
  • Revenue Growth
  • YMAB N/A
  • BOC 11.51
  • 52 Week Low
  • YMAB $6.09
  • BOC $12.41
  • 52 Week High
  • YMAB $20.90
  • BOC $16.99
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 32.17
  • BOC 43.47
  • Support Level
  • YMAB $9.31
  • BOC $14.78
  • Resistance Level
  • YMAB $11.10
  • BOC $15.60
  • Average True Range (ATR)
  • YMAB 0.72
  • BOC 0.33
  • MACD
  • YMAB -0.00
  • BOC -0.04
  • Stochastic Oscillator
  • YMAB 3.87
  • BOC 13.85

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a us-based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. They generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: